CIK 0001860657 · <br>Emerging growth company
Allarity Therapeutics, Inc.
Sign in to watch- Ticker
- ALLR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 401-426-4664
- Business address
- 24 SCHOOL ST., 2ND FLOOR, BOSTON, MA, 02108
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-22 | Jensen Thomas CEO | Grant or award | +396,734 | 396,734 | ||
| 2025-01-22 | McLaughlin Gerald W. Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2025-01-22 | Vazzano Joseph Walter Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2025-01-22 | Benjamin Laura Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-09-30 | Graff Jeremy R. See Remarks | Grant or award | +118,483 | $2.11 | $250K | 118,483 |
Page 2 of 2 · 25 trades